文献速递儿科影像腹部CTMR

儿童肝母细胞瘤临床试验中中央影像复核的效用

Usefulness of central radiologic review in clinical trials of children with hepatoblastoma.
PubMed 文献 · Pediatr Radiol · 2022-10-18

本研究纳入91例日本儿童肝母细胞瘤临床试验患儿,比较局部预处理肿瘤范围(PRETEXT)分期与中央复核结果。PRETEXT分期一致率为70%,分期越高一致率越低;中央复核发现143个病灶(157.1%),约为局部诊断的1.8倍,且纠正了局部对肝静脉、门静脉侵犯及肝外病变的假阳性判断。

要点

  • PRETEXT分期一致率70%,分期越高一致率越低,III/IV期尤需中央复核。
  • 中央复核发现病灶数约为局部诊断1.8倍,最常见额外标准为「多灶病变」。
  • 局部诊断对肝静脉、门静脉侵犯及肝外病变假阳性多,中央复核可纠正。

关键影像表现/征象

  • 中央复核采用额外标准识别143个病灶(157.1%),约为局部诊断的1.8倍。
  • 中央复核最常发现的额外标准为「多灶病变」(n=19)。
  • 局部诊断中肝静脉病变、门静脉侵犯及肝外病变存在较多假阳性。
  • 肺转移一致率较高。

诊断标准与关键数值

  • PRETEXT分期总体一致率为70%。
  • 分期越高,局部与中央复核的一致率越低。

临床应用与阅片要点

  • 对PRETEXT III/IV期及怀疑肝静脉、门静脉侵犯的病例,建议参考中央复核以降低假阳性。
  • 报告多灶病变时需仔细评估,中央复核常补充此诊断。

局限性

  • 单中心临床试验数据,样本量91例,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: No previous research papers have reported a comparative survey of local radiologic diagnoses and central review in children with hepatoblastoma.

OBJECTIVE: To evaluate the utility of central review of children with hepatoblastoma enrolled in a clinical trial.

MATERIALS AND METHODS: The study included 91 children enrolled in a clinical trial conducted by the Japanese Study Group for Pediatric Liver Tumor. We compared the results of the initial pre-treatment extent of tumor (PRETEXT) disease staging performed at local sites with the results obtained on central review to determine the concurrence rates for tumor staging and additional criteria.

RESULTS: The concurrence rate for PRETEXT staging was 70%. As the stage increased, the concurrence rate decreased. Using additional criteria, central review identified 143 lesions (157.1%), about 1.8 times higher than the number identified for the local site diagnoses. The additional criterion found most often on central review was "multifocal lesion" (n=19). The concurrence rate for lung metastases was high. However, our central review found many false-positive assertions of hepatic vein lesions, portal vein invasion and extrahepatic lesions among the local site diagnoses.

CONCLUSION: In a clinical trial of hepatoblastoma, central review provided a more precise diagnosis than local site diagnoses with respect to severe PRETEXT stages III and IV cases and other cases including hepatic and portal vein invasion. The central review process appears to be effective and essential for improving the quality of clinical trials.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Miyazaki, Oguma, Nishikawa, et al. Usefulness of central radiologic review in clinical trials of children with hepatoblastoma. Pediatr Radiol. 2022. PMID: 36255457. doi:10.1007/s00247-022-05530-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。